July 22, 2011
Abbott Laboratories slapped Hospira Inc. with a lawsuit Thursday in Delaware federal court, claiming that Hospira infringed two patents by trying to tap into the market for paricalcitol, which Abbott markets as the kidney disease treatment Zemplar.